摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

[(1S,3S,7S,8E,11S,12S,13E,15S,17R,21R,23R,25S)-11,21-dihydroxy-17-(hydroxymethyl)-13-(2-methoxy-2-oxoethylidene)-10,10-dimethyl-12-octanoyloxy-19-oxo-6,18,27,28,29-pentaoxatetracyclo[21.3.1.13,7.111,15]nonacos-8-en-25-yl] benzoate | 1041849-36-8

中文名称
——
中文别名
——
英文名称
[(1S,3S,7S,8E,11S,12S,13E,15S,17R,21R,23R,25S)-11,21-dihydroxy-17-(hydroxymethyl)-13-(2-methoxy-2-oxoethylidene)-10,10-dimethyl-12-octanoyloxy-19-oxo-6,18,27,28,29-pentaoxatetracyclo[21.3.1.13,7.111,15]nonacos-8-en-25-yl] benzoate
英文别名
——
[(1S,3S,7S,8E,11S,12S,13E,15S,17R,21R,23R,25S)-11,21-dihydroxy-17-(hydroxymethyl)-13-(2-methoxy-2-oxoethylidene)-10,10-dimethyl-12-octanoyloxy-19-oxo-6,18,27,28,29-pentaoxatetracyclo[21.3.1.13,7.111,15]nonacos-8-en-25-yl] benzoate化学式
CAS
1041849-36-8
化学式
C45H64O15
mdl
——
分子量
844.994
InChiKey
DDNNJKCAKVBMHW-KGKBOMCVSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.5
  • 重原子数:
    60
  • 可旋转键数:
    14
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.69
  • 拓扑面积:
    203
  • 氢给体数:
    3
  • 氢受体数:
    15

反应信息

  • 作为产物:
    描述:
    氟化氢吡啶 作用下, 以 四氢呋喃 为溶剂, 以2.0 mg的产率得到[(1S,3S,7S,8E,11S,12S,13E,15S,17R,21R,23R,25S)-11,21-dihydroxy-17-(hydroxymethyl)-13-(2-methoxy-2-oxoethylidene)-10,10-dimethyl-12-octanoyloxy-19-oxo-6,18,27,28,29-pentaoxatetracyclo[21.3.1.13,7.111,15]nonacos-8-en-25-yl] benzoate
    参考文献:
    名称:
    The Design, Synthesis, and Evaluation of C7 Diversified Bryostatin Analogs Reveals a Hot Spot for PKC Affinity
    摘要:
    The first series of systematically varied C7-functionalized bryostatin analogs (12 members in all) have been synthesized through an efficient and convergent route. A new hotspot for PKC affinity, not present in the natural products, has been discovered, allowing for affinity control and potentially for selective regulation of PKC isozymes. Several analogs exhibit single-digit nanomolar affinity to PKC and display superior activity compared to bryostatin against the leukemia cell line K562.
    DOI:
    10.1021/ol801235h
点击查看最新优质反应信息

文献信息

  • BRYOSTATIN ANALOGUES, SYNTHETIC METHODS AND USES
    申请人:WENDER PAUL A.
    公开号:US20090270492A1
    公开(公告)日:2009-10-29
    Biologically active compounds related to the bryostatin family of compounds, including methods of utilizing the same.
    与拟静脉注射家族相关的生物活性化合物,包括利用这些化合物的方法。
  • US8497385B2
    申请人:——
    公开号:US8497385B2
    公开(公告)日:2013-07-30
  • The Design, Synthesis, and Evaluation of C7 Diversified Bryostatin Analogs Reveals a Hot Spot for PKC Affinity
    作者:Paul A. Wender、Vishal A. Verma
    DOI:10.1021/ol801235h
    日期:2008.8.7
    The first series of systematically varied C7-functionalized bryostatin analogs (12 members in all) have been synthesized through an efficient and convergent route. A new hotspot for PKC affinity, not present in the natural products, has been discovered, allowing for affinity control and potentially for selective regulation of PKC isozymes. Several analogs exhibit single-digit nanomolar affinity to PKC and display superior activity compared to bryostatin against the leukemia cell line K562.
查看更多